BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38383812)

  • 1. Correction to: The immune regulatory function of B7-H3 in malignancy: spotlight on the IFN-STAT1 axis and regulation of tumor-associated macrophages.
    Park R; Yu J; Shahzad M; Lee S; Ji JD
    Immunol Res; 2024 Feb; ():. PubMed ID: 38383812
    [No Abstract]   [Full Text] [Related]  

  • 2. The immune regulatory function of B7-H3 in malignancy: spotlight on the IFN-STAT1 axis and regulation of tumor-associated macrophages.
    Park R; Yu J; Shahzad M; Lee S; Ji JD
    Immunol Res; 2024 Jan; ():. PubMed ID: 38265550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression of B7-H3 on monocyte/macrophages in tumor microenvironment promotes lung cancer progression by inhibiting apoptosis.
    Zhang D; Huang H; Gao X; Yu G; Zhang X; Jin H; Xu R; Wang Z; Zhang G
    Transl Oncol; 2024 Mar; 41():101874. PubMed ID: 38262113
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibiting PP2A Upregulates B7-H3 Expression and Potentially Increases the Sensitivity of Malignant Meningiomas to Immunotherapy by Proteomics.
    Hu B; Hao S; Miao Y; Deng Y; Wang J; Wan H; Zhang S; Ji N; Feng J
    Pathol Oncol Res; 2022; 28():1610572. PubMed ID: 36203966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induced expression of B7-H3 on the lung cancer cells and macrophages suppresses T-cell mediating anti-tumor immune response.
    Chen C; Shen Y; Qu QX; Chen XQ; Zhang XG; Huang JA
    Exp Cell Res; 2013 Jan; 319(1):96-102. PubMed ID: 22999863
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B7-H3 Suppresses Antitumor Immunity via the CCL2-CCR2-M2 Macrophage Axis and Contributes to Ovarian Cancer Progression.
    Miyamoto T; Murakami R; Hamanishi J; Tanigaki K; Hosoe Y; Mise N; Takamatsu S; Mise Y; Ukita M; Taki M; Yamanoi K; Horikawa N; Abiko K; Yamaguchi K; Baba T; Matsumura N; Mandai M
    Cancer Immunol Res; 2022 Jan; 10(1):56-69. PubMed ID: 34799346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of B7-H3 in tumors and its potential in clinical application.
    Feng R; Chen Y; Liu Y; Zhou Q; Zhang W
    Int Immunopharmacol; 2021 Dec; 101(Pt B):108153. PubMed ID: 34678689
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of MYC-miR-29-B7-H3 in Medulloblastoma Growth and Angiogenesis.
    Purvis IJ; Avilala J; Guda MR; Venkataraman S; Vibhakar R; Tsung AJ; Velpula KK; Asuthkar S
    J Clin Med; 2019 Aug; 8(8):. PubMed ID: 31382461
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B7-H3 on breast cancer cell MCF7 inhibits IFN-γ release from tumour-infiltrating T cells.
    Shao L; Yu Q; Xia R; Zhang J; Gu S; Yu D; Zhuang Z
    Pathol Res Pract; 2021 Aug; 224():153461. PubMed ID: 34265738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer cell-expressed B7-H3 regulates the differentiation of tumor-associated macrophages in human colorectal carcinoma.
    Mao Y; Chen L; Wang F; Zhu D; Ge X; Hua D; Sun J
    Oncol Lett; 2017 Nov; 14(5):6177-6183. PubMed ID: 29113264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HDAC is indispensable for IFN-γ-induced B7-H1 expression in gastric cancer.
    Deng R; Zhang P; Liu W; Zeng X; Ma X; Shi L; Wang T; Yin Y; Chang W; Zhang P; Wang G; Tao K
    Clin Epigenetics; 2018 Dec; 10(1):153. PubMed ID: 30537988
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B7-H3 augments the pro-angiogenic function of tumor-associated macrophages and acts as a novel adjuvant target for triple-negative breast cancer therapy.
    Cheng N; Bei Y; Song Y; Zhang W; Xu L; Zhang W; Yang N; Bai X; Shu Y; Shen P
    Biochem Pharmacol; 2021 Jan; 183():114298. PubMed ID: 33153969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of B7-H3, a potential factor of tumor immune evasion in combination with the number of regulatory T cells, affects against recurrence-free survival in breast cancer patients.
    Maeda N; Yoshimura K; Yamamoto S; Kuramasu A; Inoue M; Suzuki N; Watanabe Y; Maeda Y; Kamei R; Tsunedomi R; Shindo Y; Inui M; Tamada K; Yoshino S; Hazama S; Oka M
    Ann Surg Oncol; 2014 Dec; 21 Suppl 4(Suppl 4):S546-54. PubMed ID: 24562936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-34a induces immunosuppression in colorectal carcinoma through modulating a SIRT1/NF-κB/B7-H3/TNF-α axis.
    Meng F; Yang M; Chen Y; Chen W; Wang W
    Cancer Immunol Immunother; 2021 Aug; 70(8):2247-2259. PubMed ID: 33492448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNATUG1 Facilitates Th2 Cell Differentiation by Targeting the miR-29c/B7-H3 Axis on Macrophages.
    Sun H; Wang T; Zhang W; Dong H; Gu W; Huang L; Yan Y; Zhu C; Chen Z
    Front Immunol; 2021; 12():631450. PubMed ID: 34335559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B7-H3 Expression in Merkel Cell Carcinoma-Associated Endothelial Cells Correlates with Locally Aggressive Primary Tumor Features and Increased Vascular Density.
    Aung PP; Parra ER; Barua S; Sui D; Ning J; Mino B; Ledesma DA; Curry JL; Nagarajan P; Torres-Cabala CA; Efstathiou E; Hoang AG; Wong MK; Wargo JA; Lazar AJ; Rao A; Prieto VG; Wistuba I; Tetzlaff MT
    Clin Cancer Res; 2019 Jun; 25(11):3455-3467. PubMed ID: 30808776
    [TBL] [Abstract][Full Text] [Related]  

  • 17. B7-H3 in combination with regulatory T cell is associated with tumor progression in primary human non-small cell lung cancer.
    Jin Y; Zhang P; Li J; Zhao J; Liu C; Yang F; Yang D; Gao A; Lin W; Ma X; Sun Y
    Int J Clin Exp Pathol; 2015; 8(11):13987-95. PubMed ID: 26823710
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of B7-H3 expression in tumor cells and tumor vasculature with FOXP3+ regulatory T cells in renal cell carcinoma.
    Inamura K; Amori G; Yuasa T; Yamamoto S; Yonese J; Ishikawa Y
    Cancer Manag Res; 2019; 11():7021-7030. PubMed ID: 31440091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B7-H3 augments the inflammatory response and is associated with human sepsis.
    Zhang G; Wang J; Kelly J; Gu G; Hou J; Zhou Y; Redmond HP; Wang JH; Zhang X
    J Immunol; 2010 Sep; 185(6):3677-84. PubMed ID: 20696859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. To kill a cancer: Targeting the immune inhibitory checkpoint molecule, B7-H3.
    Kanchan RK; Doss D; Khan P; Nasser MW; Mahapatra S
    Biochim Biophys Acta Rev Cancer; 2022 Sep; 1877(5):188783. PubMed ID: 36028149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.